Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,273.80
14.6 (0.65%)
BSENSE

Mar 30

BSE+NSE Vol: 1.35 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.65%
-2.22%
1W
-0.27%
-1.03%
1M
-10.34%
-10.33%
YTD
-7.98%
-15.57%
1Y
-20.85%
-7.06%
3Y
78.18%
24.13%
5Y
59.58%
43.5%
10Y
21.69%
183.94%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.84%
0%
-4.84%
6 Months
-14.41%
0%
-14.41%
1 Year
-20.85%
0%
-20.85%
2 Years
17.02%
2.30%
19.32%
3 Years
78.18%
6.08%
84.26%
4 Years
37.98%
8.28%
46.26%
5 Years
59.58%
11.26%
70.84%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-20.52%
2
Quartile
quartile-2
2025
9.98%
4
Quartile
quartile-4
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-7.59%
3
Quartile
quartile-3
Sep-Dec
-6.99%
3
Quartile
quartile-3
Sep-Dec
-6.99%
3
Quartile
quartile-3
1Y
-20.52%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-20.52%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available